Abstract
Treatment of patients with HNSCC has not improved consiagnosis, most patients present with advanced stage tumors. Immunotherapy has gained interest over the last years to improve disease-free survival of patients with HNSCC. One of the hurdles to overcome is the poor immunogenic and strong immune suppressive properties of HNSCC. Apart
... read more